Premium
Event‐free survival at 24 months captures central nervous system relapse of systemic diffuse large B‐cell lymphoma in the immunochemotherapy era
Author(s) -
Thanarajasingam Gita,
Maurer Matthew J.,
Farooq Umar,
Johnston Patrick B.,
Thompson Carrie A.,
Bennani Nabila N.,
Ansell Stephen M.,
Porrata Luis F.,
Macon William R.,
Syrbu Sergei I.,
Cerhan James R.,
Habermann Thomas M.,
Link Brian K.,
Witzig Thomas E.,
Nowakowski Grzegorz S.
Publication year - 2018
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.14922
Subject(s) - medicine , rituximab , diffuse large b cell lymphoma , lenalidomide , vincristine , oncology , population , ibrutinib , cyclophosphamide , lymphoma , chemotherapy , leukemia , chronic lymphocytic leukemia , multiple myeloma , environmental health